Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

Why Beam Therapeutics Is Back On Investors’ Radar Beam Therapeutics (BEAM) is in focus after securing U.S. FDA alignment on a ...

Aurora Therapeutics has emerged from stealth with $16 million in funding from Menlo Ventures to expand the potential of gene ...

The company in 2026 is seeking approval from global regulators for Casgevy and two cystic fibrosis drugs in younger patients.

Heat stress is one of the biggest hidden costs in dairy production. When temperatures rise beyond an animal’s comfort ...